Jamie Kariya, Vancouver

About Jamie

Jamie advises clients on a range of business transactions, including mergers and acquisitions and public and private financings. He also provides ongoing advice to issuers regarding corporate governance, continuous disclosure obligations, and various other Canadian corporate and securities law compliance matters. Jamie has extensive expertise advising clients in the mining and biotechnology industries.

Jamie spent over a year in the Firm's New York office, where he focused on Canada/U.S. cross-border M&A transactions and financings.

Select Experience

Recent representative transactions include acting as counsel to:

Mergers & Acquisitions

Fission Uranium Corp. in connection with its proposed C$1.1-billion acquisition by Paladin Energy
Equinox Gold Corp. in connection with its acquisition of 40% of the Greenstone Mine for US$995-million and the associated US$299-million bought deal equity offering and US$500-million debt facility
Maverix Metals Inc. in connection with its acquisition by Triple Flag Precious Metals Corp. for US$600-million
Great Bear Resources Ltd. in connection with its acquisition by Kinross Gold Corporation for C$1.8-billion
Great Bear Royalties Corp. in connection with its proposed acquisition by International Royalty Corporation for C$200-million in cash
Capstone Mining Corp. in connection with its C$1.1-billion business combination with Mantos Copper
Equinox Gold Corp. in connection with its C$1.3-billion merger of equals with Leagold Mining Corporation and its C$700-million acquisition of Premier Gold
Equinox Gold Corp. in connection with the acquisition of the Mesquite mine from New Gold Inc. for US$158-million and its sale of the Mercedes Mine to Bear Creek Mining Corporation
PlayAGS Inc. in connection with the acquisition of Integrity Gaming Corp.

Corporate Finance

Solaris Resources Inc. in connection with the US$80-million financing package made available by Orion Mine Finance to fund the Warintza Project in Ecuador
Capstone Copper Corp. in connection with its C$328-million secondary offering of common shares
AbCellera Biologics Inc. in connection with its US$555.5-million initial public offering of common shares on NASDAQ
Xenon Pharmaceuticals Inc. in connection with its US$345-million public offering of common shares and pre-funded warrants
Zymeworks Inc. in connection with its US$320.8-million cross-border public offering of common shares and pre-funded warrants
Ero Copper Corp. in connection with its C$127-million initial public offering
Bluestone Resources Inc. in connection with its C$92-million bought deal financing